Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093282
Filing Date
2024-08-08
Accepted
2024-08-08 06:45:23
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sybx-20240630.htm   iXBRL 10-Q 2154808
2 EX-10.2 sybx-ex10_2.htm EX-10.2 51150
3 EX-10.3 sybx-ex10_3.htm EX-10.3 72451
4 EX-10.4 sybx-ex10_4.htm EX-10.4 19616
5 EX-10.5 sybx-ex10_5.htm EX-10.5 72017
6 EX-10.6 sybx-ex10_6.htm EX-10.6 14444
7 EX-31.1 sybx-ex31_1.htm EX-31.1 14114
8 EX-31.2 sybx-ex31_2.htm EX-31.2 13976
9 EX-32.1 sybx-ex32_1.htm EX-32.1 7233
10 EX-32.2 sybx-ex32_2.htm EX-32.2 7118
11 GRAPHIC img121611604_0.jpg GRAPHIC 70319
12 GRAPHIC img141064427_0.jpg GRAPHIC 5382
13 GRAPHIC img142911469_0.jpg GRAPHIC 5382
  Complete submission text file 0000950170-24-093282.txt   8019706

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sybx-20240630.xsd EX-101.SCH 1094258
79 EXTRACTED XBRL INSTANCE DOCUMENT sybx-20240630_htm.xml XML 1113718
Mailing Address PO BOX 30 WINCHESTER MA 01890
Business Address PO BOX 30 WINCHESTER MA 01890 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 241185908
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)